These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 601749)

  • 21. On the reliability of the use of heparin immobilized on agarose for the study of the interactions among heparin, thrombin and antithrombin.
    Fish WW; Björk I
    Thromb Haemost; 1982 Aug; 48(1):84-6. PubMed ID: 7135347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antiheparin effect of alpha1-acid glycoprotein probably due to steric hindrance of the heparin-thrombin interaction.
    Andersen P; Godal HC
    Thromb Res; 1979; 15(5-6):857-68. PubMed ID: 494182
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of thrombin and antithrombin. Reaction observed by intrinsic fluorescence measurements.
    Wong RF; Windwer SR; Feinman RD
    Biochemistry; 1983 Aug; 22(17):3994-9. PubMed ID: 6615813
    [No Abstract]   [Full Text] [Related]  

  • 24. Differences in the effect of antithrombin on thrombin clotting and thrombin esterase activity.
    Gans H; Boulton A
    Thromb Diath Haemorrh; 1969 Aug; 22(1):28-31. PubMed ID: 5821245
    [No Abstract]   [Full Text] [Related]  

  • 25. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.
    Olson ST; Björk I; Shore JD
    Methods Enzymol; 1993; 222():525-59. PubMed ID: 8412815
    [No Abstract]   [Full Text] [Related]  

  • 26. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
    Fan B; Turko IV; Gettins PG
    Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actions and interactions of antithrombin and heparin.
    Rosenberg RD
    N Engl J Med; 1975 Jan; 292(3):146-51. PubMed ID: 127943
    [No Abstract]   [Full Text] [Related]  

  • 28. A fragment of antithrombin that binds both heparin and thrombin.
    Rosenfeld L; Danishefsky I
    Biochem J; 1986 Aug; 237(3):639-46. PubMed ID: 3800906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A differential effect of low-affinity heparin on the inhibition of thrombin and factor Xa by antithrombin.
    Nordenman B; Nordling K; Björk I
    Thromb Res; 1980 Feb 1-15; 17(3-4):595-600. PubMed ID: 7368180
    [No Abstract]   [Full Text] [Related]  

  • 30. Activation of heparin cofactor II by heparin oligosaccharides.
    Maimone MM; Tollefsen DM
    Biochem Biophys Res Commun; 1988 May; 152(3):1056-61. PubMed ID: 3377765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractionation of heparin by chromatography on immobilized thrombin. Correlation between the anticoagulant activity of the fractions and their content of heparin with high affinity for antithrombin.
    Nordenman B; Björk I
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):711-8. PubMed ID: 7444870
    [No Abstract]   [Full Text] [Related]  

  • 32. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity toward thrombin-antithrombin of heparin immobilized on two hydrogels.
    Tay SW; Merrill EW; Salzman EW; Lindon J
    Biomaterials; 1989 Jan; 10(1):11-5. PubMed ID: 2713428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of rabbit thrombomodulin on the inhibition of thrombin by the antithrombin-heparin complex: role of the acid domain of thrombomodulin].
    Bourin MC
    C R Acad Sci III; 1987; 304(8):173-6. PubMed ID: 3028582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of heparin on thrombin-antithrombin reaction.
    Machovich R; Blaskó G; Pálos LA
    Biochim Biophys Acta; 1975 Jan; 379(1):193-200. PubMed ID: 1115795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of factor X and prothrombin in antithrombin-III depleted plasma: the effects of heparin.
    Ofosu FA; Blajchman MA; Modi G; Cerskus AL; Hirsh J
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):331-45. PubMed ID: 7324001
    [No Abstract]   [Full Text] [Related]  

  • 37. Routes of thrombin action in the production of proteolytically modified, secondary forms of antithrombin-thrombin complex.
    Fish WW; Orre K; Björk I
    Eur J Biochem; 1979 Nov; 101(1):39-44. PubMed ID: 510313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin.
    Griffith MJ
    J Biol Chem; 1982 Jul; 257(13):7360-5. PubMed ID: 7085630
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of fibrin-bound thrombin by a covalent antithrombin-heparin complex.
    Berry LR; Becker DL; Chan AK
    J Biochem; 2002 Aug; 132(2):167-76. PubMed ID: 12153711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.
    Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U
    Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.